IP INTERCEPT PHARMACEUTICALS INC Stock: price and management transactions · United States · SEC (Form 4)Follow the INTERCEPT PHARMACEUTICALS INC share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was filed on 12 February 2016 (Attribution). Among the most active insiders: Duncan Barbara Gayle. The full history is accessible without an account.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 February 2016
All Executives18 Thresholds0 Prospectus0 Other0
Declarations 18 total
◆ Chief Financial Officer · Executives · 10 Feb 2016
6,200 shares Common Stock SEC:0001144204-16-081813:0
◆ CMO and EVP - Development · Executives · 10 Feb 2016
7,800 shares Common Stock SEC:0001144204-16-081812:0
◆ Chief Strategy Officer · Executives · 10 Feb 2016
6,700 shares Common Stock SEC:0001144204-16-081815:0
◆ See Remarks · Executives · 10 Feb 2016
23,300 shares Common Stock SEC:0001144204-16-081816:0
◆ See Remarks · Executives · 10 Feb 2016
7,800 shares Common Stock SEC:0001144204-16-081814:0
▼ Chief Strategy Officer · Executives · 1 Feb 2016
128 shares Common Stock SEC:0001144204-16-078888:0
▼ See Remarks · Executives · 12 Jan 2016
624 shares Common Stock SEC:0001144204-16-075725:0
▼ See Remarks · Executives · 13 Jan 2016
104 shares Common Stock SEC:0001144204-16-075725:1
◇ Chief Financial Officer · Executives · 1 Jan 2016
1,298 shares Common Stock SEC:0001144204-16-074239:0
▼ Chief Financial Officer · Executives · 4 Jan 2016
40 shares Common Stock SEC:0001144204-16-074239:1
▼ Chief Financial Officer · Executives · 4 Jan 2016
428 shares Common Stock SEC:0001144204-16-074239:2
◇ CEO & President · Executives · 1 Jan 2016
4,868 shares Common Stock SEC:0001144204-16-074237:0
▼ CEO & President · Executives · 4 Jan 2016
2,001 shares Common Stock SEC:0001144204-16-074237:1
▼ CEO & President · Executives · 4 Jan 2016
125 shares Common Stock SEC:0001144204-16-074237:2
◇ CMO and EVP - Development · Executives · 1 Jan 2016
1,623 shares Common Stock SEC:0001144204-16-074238:0
▼ CMO and EVP - Development · Executives · 4 Jan 2016
37 shares Common Stock SEC:0001144204-16-074238:1
▼ CMO and EVP - Development · Executives · 4 Jan 2016
496 shares Common Stock SEC:0001144204-16-074238:2
▼ Chief Strategy Officer · Executives · 4 Jan 2016
469 shares Common Stock SEC:0001144204-16-074240:0
关于 INTERCEPT PHARMACEUTICALS INC INTERCEPT PHARMACEUTICALS INC 是一家生物制药公司，专注于开发肝脏疾病治疗方法。该公司在纳斯达克上市，股票代码为 ICPT。